Enhanced expression of a-series gangliosides in fibroblasts of patients with peroxisome biogenesis disorders.
Peroxisome biogenesis disorders (PBD) are classified into Zellweger syndrome (ZS), infantile Refsum disease (IRD) and neonatal adrenoleukodystrophy. Disturbances in the differentiation of neural cells such as migration arrest are characteristic of PBD. So far the pathogenesis of these disturbances is not clearly understood. We describe an altered metabolism of glycosphingolipids in PBD which has not yet been investigated. We observed an increased amount of a-series gangliosides, GM2, GM1 and GD1a, in the fibroblasts of patients with ZS and IRD. Gangliosides GM1 and GD1a were not present in detectable amounts in normal subjects. A key step in the synthesis of a-series gangliosides is a transfer of GalNAc to ganglioside GM3, so we determined the level of ganglioside GM3 by immunohistochemical methods. We found a granular structure, which was positive toward anti-ganglioside GM3 antibody in the cytoplasm of the patients' fibroblasts. In control cells, the cell membrane was slightly positive toward anti-GM3 antibody. These results may help to clarify the pathogenesis of PBD with respect to the functional roles of glycosphingolipids in cell differentiation, proliferation and apoptosis.
Tatsumi
K
K
Department of Pediatrics, Faculty of Medicine, University of Tokyo, Japan.
Saito
M
M
Lin
B
B
Iwamori
M
M
Ichiseki
H
H
Shimozawa
N
N
Kamoshita
S
S
Igarashi
T
T
Sakakihara
Y
Y
D005347:Fibroblasts / Q000378:metabolism*; D005679:G(M3) Ganglioside / Q000032:analysis; D005732:Gangliosides / Q000032:analysis / Q000096:biosynthesis / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D007223:Infant; D018901:Peroxisomal Disorders / Q000209:etiology / Q000378:metabolism*; D012035:Refsum Disease / Q000378:metabolism; D015211:Zellweger Syndrome / Q000378:metabolism
D005679:G(M3) Ganglioside; D005732:Gangliosides; C021298:ganglioside, GD1a